Preconceptional identification of cystic fibrosis carriers in the Sardinian population: A pilot screening program

Journal of Cystic Fibrosis

Volumn 10, Issue 3, 2011, Pages 207-211

  Coiana, Alessandra ^a   Faa', Valeria ^b   Carta, Daniela ^a   Puddu, Rosalba ^c   Cao, Antonio ^b   Rosatelli, Maria Cristina ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Milan Unit   (Italy)

^c Osp Regionale per le Microcitemie   (Italy)

Author keywords

Cystic fibrosis; Genetic counseling; Genetic testing; Preconceptional screening

Indexed keywords

ARTICLE; CYSTIC FIBROSIS; FEMALE; GEL ELECTROPHORESIS; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; ISOLEUCINE; ITALY; MALE; MUTATION; PHENYLALANINE; PILOT PROJECTS; THREONINE;

EID: 79955959370     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.02.006     Document Type: Article

References (18)

1. Cao A., Furbetta M., Galanello R., et al. Prevention of homozygous β-thalassemia by carrier screening and prenatal diagnosis in Sardinia. Am J Hum Genet 1981, 33:592-605.
2. Kaback M.M., Zeiger R.S., Reynolds L.W., Sonnerborn M. Approaches to the control and prevention of Tay-Sachs disease. Prog Med Genet 1974, 10:103-134.
3. NIH Consensus Statement Genetic testing for cystic fibrosis. Arch Intern Med 1999, 159:1529-1539.
4. Grody W.W., Cutting G., Klinger K., Richards C.S., Watson M.S., Desnick R.J. Subcommittee on Cystic Fibrosis Screening, Accreditation of Genetic Service Committee, ACMG American College of Medical Genetics. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001, 3:149-154.
5. Watson M.S., Cutting G.R., Desnick R.J., et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 2004, 6:387-391.
6. Abeliovich D., Lavon I.P., Lerer I., et al. Screening for five mutations detects 97% of cystic fibrosis chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. Am J Hum Genet 1992, 51:951-956.
7. Casals T., Ramos M.D., Gimenez J., Larriba S., Nunes V., Estivill X. High heterogeneity for cystic fibrosis in Spanish families: 75 mutations account for 90% of chromosomes. Hum Mut 1997, 101:365-370.
8. Rendine S., Calafell F., Cappello N., et al. Genetic history of cystic fibrosis mutations in Italy. Regional distribution. Ann Hum Genet 1997, 61:411-424.
9. Bonizzato A., Bisceglia L., Marigo C., et al. Analysis of the complete coding region of the CFTR gene in a cohort of CF patients from north-eastern Italy: identification of 90% of the mutations. Hum Genet 1995, 95:397-402.
10. Castaldo G., Rippa E., Sebastio G., et al. Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure. J Med Genet 1996, 33:475-479.
11. Castaldo G., Fuccio A., Cazeneuve C., et al. Detection of five rare cystic fibrosis mutations peculiar to Southern Italy: implications in screening for the disease and phenotype characterization for patients with homozygote mutations. Clin Chem 1999, 45:957-962.
12. Faa' V., Pellegrini Bettoli P., Demurtas M., et al. A new insertion/deletion of the cystic fibrosis transmembrane conductance regulator gene accounts for 3.4% of cystic fibrosis mutations in Sardinia: implications for population screening. J Mol Diagn 2006, 8:499-503.
13. Casals T., Aparisi L., Martinez-Costa C., et al. Different CFTR mutational spectrum in alcoholic and idiopathic chronic pancreatitis. Pancreas 2004, 28:374-379.
14. Dork T., Dworniczak B., Aulehla-Sholz C., et al. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet 1997, 100:365-377.
15. Dequeker E., Stuhrmann M., Morris M.A., et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and CFTR-related disorders-updated European recommendations. Eur J Hum Genet 2009, 17:51-65.
16. Saba L., Leoni G.B., Meloni A., Faà V., Cao A., Rosatelli M.C. Two novel mutations in the transmembrane domains of the CFTR gene in subjects of Sardinian descent. Hum Mol Genet 1993, 2:1739-1740.
17. Leoni G.B., Pitzalis S., Podda R., et al. A specific cystic fibrosis mutation (T338I) associated with the phenotype of isolated with the phenotype of isolated hypotonic dehydration. J Pediatr 1995, 127:281-283.
18. World Health Organisation: Classification of cystic fibrosis and related disorders Report of joint working group of WHO/ICF(M)A/ECFS/ECFTN. J Cyst Fibros 2002, 1:5-8.